If an oral drug demonstrates unexpectedly low bioavailability despite excellent absorption from the small intestine, which pharmacokinetic process is most likely responsible?

💡 Explanation

Extensive first-pass metabolism in the liver significantly reduces bioavailability of orally administered drugs because a large fraction is metabolized before reaching systemic circulation. Therefore, if absorption is good, but bioavailability is low, first-pass metabolism is the dominant factor, rather than renal reabsorption, tissue binding, or biliary excretion.

• If a drug inhibits the urea cycle within liver hepatocytes, which consequence follows for the body's nitrogen balance?
• Why does pulmonary edema worsen when lymphatic drainage is blocked, causing increased interstitial fluid and alveolar flooding?
• Why does thyroxine (T4) conversion to triiodothyronine (T3) decrease during prolonged starvation?
• Why does resistance training in aging adults lead to muscle hypertrophy, despite decreased satellite cell activation?
• Which endocrine imbalance results if human chorionic gonadotropin (hCG) declines rapidly during early pregnancy?
• If a patient with emphysema experiences increased physiological dead space in their lungs due to alveolar damage, which consequence follows regarding respiratory gas exchange?